# Edgewise Therapeutics, Inc.: Form 8-K, filed Nov 6, 2025

- Company: [Edgewise Therapeutics, Inc.](/companies/ewtx.md) (CIK 1710072)
- Form: 8-K
- Filed: 2025-11-06
- Accepted by EDGAR: Nov 6, 2025, 08:00 ET
- Period: 2025-11-06
- Accession: 0001104659-25-107419
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1710072/000110465925107419/tm2529979d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1710072/000110465925107419/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1710072/000110465925107419/tm2529979d1_8k.htm

Filed Nov 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-107419. Last ingested by Listed: Nov 11, 2026, 03:33 ET. No prices; not investment advice.